Investment
Features
FeesSafety
Academy
More
Pluang+

Compare EPR Properties (EPR) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance

EPR PropertiesTrade
Nuvation Bio Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

EPR Properties vs Nuvation Bio Inc. Class A Common Stock — how do they compare? EPR Properties trades at $54.87 (market cap $4.14B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: EPR Properties is far larger — about 2.4× Nuvation Bio Inc. Class A Common Stock's market cap, and EPR Properties pays a 6.88% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold EPR Properties for 45 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.

EPRNUVB
Market Cap
$4.14B$1.71B
Volume
874,6215,448,712
Sector
Real EstateHealth
52-Week High
$64.32$9.54
52-Week Low
$48.71$3.41
Typical Hold Time
45 Days0 Days
Enterprise Value
$7.65B$1.30B
Dividend Yield
6.88%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

EPR Properties

EPR Properties trades at $54.08, down 2.15% on the day, with a bearish technical signal. The REIT maintains strong fundamentals, including a 91.41% gross margin and a 37.66% net income margin, though net income is projected to dip slightly in 2026. Recent news highlights its focus on monthly dividends and diversification beyond theaters into experiential properties.

The outlook is mixed; analyst consensus is a 'Buy' with a $65.50 price target, suggesting significant upside, but technical indicators and a recent earnings miss signal near-term caution. Key risks include exposure to interest rate sensitivity and execution of its diversification strategy amidst a bearish market sentiment.

Nuvation Bio Inc. Class A Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EPR

No sentiment data available yet.

NUVB
100% Buy0% Sell
Avg holding period · 0 Days

About EPR Properties

EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.

Read more on EPR →

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →